ResMed’s neuromuscular disease and restrictive lung disease solutions

ResMed’s ventilation solutions

ResMed is committed to improving the quality of life for neuromuscular disease (NMD) and restrictive lung disease (RLD) patients through the use of home ventilation systems.

Treating a patient with respiratory failure can help alleviate some of the symptoms of poor respiration. The ideal treatment for respiratory insufficiency or respiratory failure in these patients is non-invasive ventilation (NIV). 

Special considerations

Ventilatory dependency is likely to increase over time with progressive neuromuscular disease. Consequently, ventilator settings may also need to be changed.

  • ResMed’s ventilators caters to a range of patients, from those who are non-dependent to those who are dependent on ventilation. For extra versatility, ResMed ventilators offer both non-invasive and invasive options.
  • ResMed's advanced data collection capabilities (device and card data storage with high-resolution flow and pressure data, percentage of spontaneous breaths, AHI, volumes, respiratory rate, synchronization details, SpO2 monitoring), in addition to our AirView™ patient management system and ResScan™ software, allow clinicians to have detailed data for troubleshooting and monitoring patient progress.

ResMed's NIV solutions include:

Astral™ series:  The Astral life support ventilator was designed for both hospital and home use. Intended for both invasive and non-invasive applications, and pediatric (5 kg and up) to adult, Astral has an 8-hour internal battery to promote intrafacility transport.  Its size and weight allow it to be used during transfer and mobilization of patients in critical care areas, offering seamless continuity of care from the hospital to the home.

Stellar series For use in the hospital setting, from invasive to non-invasive and pediatric to adult, ResMed’s Stellar™ series of ventilators offers high-quality ventilation in one easily accessible device.  Light, small and quiet, Stellar combines unique technology, like ResMed’s iVAPS automated pressure support algorithms with optimal setup capabilities like pathology defaults and real-time monitoring.

S9 VPAP ST-A with iVAPS:  Designed for both hospital and home, the S9 VPAP ST-A provides non-invasive ventilation support to pediatric (15 kg and up) and adult patients with respiratory insufficiency.  Using the latest automation technology, intelligent volume assured pressure support (iVAPS), it automatically adjusts to a patient’s respiratory rate, targets alveolar ventilation and adjusts pressure support as needed to accommodate each patient’s unique needs, even as their disease progresses.

Neuromuscular and restrictive lung disease patients may also have obstructive sleep apnea (OSA)

If OSA is present, EPAP needs to be titrated to overcome upper airway collapse. 

  • AHI data viewed on AirView™ and/or ResScan™ will help identify the need for EPAP adjustment.
  • High-resolution flow data can help titrate EPAP and identify PEEPi.

It is essential to maintain reliable breath triggering and cycling synchronization between the patient and the device.

  • The VSync leak management algorithm works in sync with the TiControl feature (TiControl allows the clinician to manage the patient’s inspiratory time according to their disease state). Vsync monitors and compensates for leak by continuously and automatically adjusting the baseline flow, while TiControl assures a minimum and maximum inspiratory time.
  • Trigger and cycle adjustment can also help with synchronization.

Ventilatory adjuncts, such as mouth ventilation with a mouthpiece attached to a support on a wheelchair, can be helpful.  ResMed’s Astral and Stellar series of ventilators can be used with a mouthpiece.

Patients with neuromuscular weakness may need secretion clearance.1

  • Astral ventilators allow clinicians to set four programs (Stellar allows two set programs), one of which can be set to assist in secretion clearance techniques. 

Battery backup gives patients extra mobility.

  • Astral and Stellar ventilators have internal batteries.
  • Astral can deliver an impresssive 24-hour total run-time with the combination of its internal and external batteries. (Up to 8* hours internal battery + 8 hours first external battery + 8 hours second external battery) 
  • All ResMed devices are compatible with the ResMed Power Station II. 

During all stages of ventilation, it is vital to monitor the patient's progress.

  • ResMed's advanced data management solutions (device and card data storage with high-resolution flow and pressure data, usage hours, volumes, percentage of spontaneous breaths, respiratory rate, AHI, SpO2 and synchronization details), in addition to our AirView™ cloud-based patient management system and ResScan software, allow clinicians to have detailed data for troubleshooting and monitoring patient progress as required. Some ResMed ventilators such as the Astral and Stellar can display live data (such as flow and pressure curves) as well as summary data on the device itself.
  • Real-time therapy monitoring allows titration of the patient, optimal follow-up, and adjustment of the settings as the disease progresses.2
  • 01

    C Senent et al. A comparision of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis. 2011; 12:26–32

  • 02

    Rabec et al. Evaluating noninvasive ventilation using a monitoring system coupled to a ventilator: A bench-to-bedside study. Eur Respir J. 2009; 34:902–913.

*8 hours per battery at EPAP 5 cm H2O, IPAP 15 cm H2O and 20 bpm (two batteries can be connected simultaneously)

More about NMD